Bridging Studies Between Age Groups in Vaccines
Bridging Studies Between Age Groups in Vaccines Designing Age-Group Immunobridging Studies for Vaccines What Immunobridging Aims to Show—and When Regulators Expect It Age-group immunobridging studies answer a practical question: if a vaccine’s dose and schedule are proven in one population (often adults), can we infer comparable protection in another (adolescents, children, older adults) without running…
Read More “Bridging Studies Between Age Groups in Vaccines” »